Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.507EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.507EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.507ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.507ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.54EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.54ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.54ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.54EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.54EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.54ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.196EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.196EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.196ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.196ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.196EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.196EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.196ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.196ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.57EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.57ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.57ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.57EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.57EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.34ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.34ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.34EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.34EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.459EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.459EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.459ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.459ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.459EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.459EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used